ZEBRA CAPITAL MANAGEMENT LLC – Halozyme Therapeutics, Inc. Transaction History
ZEBRA CAPITAL MANAGEMENT LLC portfolio value:
$208,000
portfolio value
ZEBRA CAPITAL MANAGEMENT LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -23.56% | -1.62K shares | -95K | $39.54 | 5.25K |
| Q2 2022 | share | Increase | +9.73% | 610 shares | 53K | $44 | 6.87K |
| Q1 2022 | share | Decrease | -7.31% | -494 shares | -22K | $39.88 | 6.26K |
| Q4 2021 | share | Decrease | -26.94% | -2.49K shares | -104K | $40.32 | 6.76K |
| Q3 2021 | share | Decrease | -1.03% | -96 shares | -49K | $40.68 | 9.25K |
| Q2 2021 | share | Decrease | -9.74% | -1.00K shares | -7K | $45.41 | 9.35K |
| Q1 2021 | share | Increase | 0.00% | 10.35K shares | 432K | $41.69 | 10.35K |
| Q4 2019 | share | Decrease | -100.00% | -13.5K shares | -211K | $17.73 | 0 |
| Q3 2019 | share | Increase | 0.00% | 13.5K shares | 211K | $15.51 | 13.5K |